5. Clinically significant (as defined by screening ophthalmologist, central reading center, and sponsor) ERG reading, retinal disease (e.g. retinitis pigmentosa including Mertk mutations), retinal hemorrhage or any disorder which affects ERG, and may inhibit follow up for retinal toxicity